Anthony S. Fiorino, Chief Medical Officer and COO at IMMUNE PHARMACEUTICALS INC (IMNP), bought 25,000 shares at $0.24 ($6K) on 2018-05-22, disclosed to the SEC on 2018-05-23.
Open-market purchase of $6k IMNP by Chief Medical Officer and COO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| BCLI | BUY | 2014-09-19 | $3K | — | Filing → |
| BCLI | BUY | 2014-09-16 | $5K | — | Filing → |